IL-13 neutralization attenuates carotid artery intimal hyperplasia and increases endothelial cell migration via modulating the JAK-1/STAT-3 signaling pathway

Qi Li,Yue Li,Fengjiao Wu,Jingyu Li,Zhongsha Li,Xiaoling Qin,Simeng Wei,Chang Chen,Qi LiYue LiFengjiao WuJingyu LiZhongsha LiXiaoling QinSimeng WeiChang Chena The Biotherapy Center,Tumor Hospital of Harbin Medical University,Harbin,P. R. Chinab Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin,P. R. China
DOI: https://doi.org/10.1080/19336918.2023.2265158
2023-10-11
Cell Adhesion & Migration
Abstract:The aim of this study was to investigate how the concentration of interleukin-13 (IL-13) affects the regulation of endothelial cell migration after injury. The incubation of recombinant human interleukin-13 (rhIL-13) strongly increased the content of reactive oxygen species (ROS) in HUVECs via the JAK-1/STAT-3/NOX-4 signaling pathway. Antagonizing the high intracellular ROS that was induced by rhIL-13 promoted the migration of HUVECs. Furthermore, IL-13 neutralization not only inhibited intimal hyperplasia, but also promoted the migration of endothelial cells (ECs) after injury. The results suggest that IL-13 inhibition is a potential means of stimulating endothelial cells recovery after injury. Therefore, the attenuation of IL-13 activation may have therapeutic value for vascular disease.
cell biology
What problem does this paper attempt to address?